Laura DeForge
Toxicologie, Pharmacologie et Signalisation Cellulaire(FR)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Immune Response and Inflammation, Cell Adhesion Molecules Research, Cell death mechanisms and regulation
Most-Cited Works
- → Safety and antitumor activity of recombinant soluble Apo2 ligand(1999)2,210 cited
- → Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions(2001)693 cited
- → Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety(2001)442 cited
- → Regulation of interleukin 8 gene expression by oxidant stress.(1993)397 cited
- → Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.(1992)335 cited
- → Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis(2010)329 cited
- → Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia(1992)324 cited
- → IL-8 in septic shock, endotoxemia, and after IL-1 administration(1991)308 cited
- → Receptor-selective Mutants of Apoptosis-inducing Ligand 2/Tumor Necrosis Factor-related Apoptosis-inducing Ligand Reveal a Greater Contribution of Death Receptor (DR) 5 than DR4 to Apoptosis Signaling(2004)280 cited
- → Structure of C3b in complex with CRIg gives insights into regulation of complement activation(2006)241 cited